Ubs Asset Management Americas Inc Sangamo Therapeutics, Inc Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $31,719 - $70,126	19,108 Added 14.31%	152,662 $268,000
Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $31,051 - $46,468	-7,272 Reduced 5.16%	133,554 $654,000
Q2 2022 Aug 12, 2022	BUY	$3.28 - $6.21 $50,964 - $96,490	15,538 Added 12.4%	140,826 $583,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $29,486 - $44,089	5,638 Added 4.71%	125,288 $727,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $148,008 - $222,723	20,303 Added 20.44%	119,650 $897,000
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $15,163 - $20,212	1,683 Added 1.72%	99,347 $895,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $41,493 - $51,571	-4,080 Reduced 4.01%	97,664 $1.17 Million
Q1 2021 May 14, 2021	SELL	$10.88 - $17.05 $9.16 Million - $14.4 Million	-841,896 Reduced 89.22%	101,744 $1.27 Million
Q4 2020 Mar 01, 2021	BUY	$9.23 - $18.18 $1.72 Million - $3.39 Million	186,575 Added 24.64%	943,640 $14.7 Million
Q3 2020 Nov 13, 2020	BUY	$9.38 - $12.48 $61,157 - $81,369	6,520 Added 0.87%	757,065 $7.15 Million
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $75,203 - $143,261	-12,110 Reduced 1.59%	750,545 $6.72 Million
Q1 2020 May 15, 2020	SELL	$5.05 - $8.85 $375,321 - $657,740	-74,321 Reduced 8.88%	762,655 $4.86 Million
Q4 2019 Feb 14, 2020	SELL	$8.03 - $11.7 $15,080 - $21,972	-1,878 Reduced 0.22%	836,976 $7.01 Million
Q3 2019 Nov 14, 2019	BUY	$9.05 - $12.22 $356,560 - $481,455	39,399 Added 4.93%	838,854 $7.59 Million
Q2 2019 Aug 15, 2019	BUY	$8.75 - $13.03 $879,138 - $1.31 Million	100,473 Added 14.37%	799,455 $0
Q4 2018 Feb 13, 2019	BUY	$9.51 - $16.6 $205,244 - $358,261	21,582 Added 3.19%	698,982 $8.02 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $563,799 - $823,017	-43,203 Reduced 6.0%	677,400 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $1.4 Million - $1.99 Million	100,500 Added 16.21%	720,603 $0
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $9.74 Million - $15.4 Million	582,981 Added 1570.45%	620,103 $0
Q4 2017 Feb 09, 2018	BUY	$11.6 - $17.35 $181,238 - $271,076	15,624 Added 72.68%	37,122 $0
Q3 2017 Nov 13, 2017	BUY	$8.4 - $15.0 $180,583 - $322,470	21,498	21,498 $0

Others Institutions Holding SGMO

# of Institutions

113

Shares Held

57.8M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$22.6 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.37M
Shares

$10.9 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.63 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.46 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.73 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account